1. Home
  2. PTLO vs EOLS Comparison

PTLO vs EOLS Comparison

Compare PTLO & EOLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Portillo's Inc.

PTLO

Portillo's Inc.

HOLD

Current Price

$4.00

Market Cap

288.1M

ML Signal

HOLD

Logo Evolus Inc.

EOLS

Evolus Inc.

HOLD

Current Price

$6.15

Market Cap

284.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTLO
EOLS
Founded
1963
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
288.1M
284.3M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
PTLO
EOLS
Price
$4.00
$6.15
Analyst Decision
Hold
Strong Buy
Analyst Count
11
5
Target Price
$8.06
$15.50
AVG Volume (30 Days)
2.2M
886.6K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1.23
EPS
N/A
N/A
Revenue
$732,066,000.00
$297,176,000.00
Revenue This Year
$9.02
$13.27
Revenue Next Year
$5.81
$17.62
P/E Ratio
N/A
N/A
Revenue Growth
3.03
11.61
52 Week Low
$3.81
$3.86
52 Week High
$12.29
$10.62

Technical Indicators

Market Signals
Indicator
PTLO
EOLS
Relative Strength Index (RSI) 32.30 55.97
Support Level N/A $5.94
Resistance Level $6.09 $6.40
Average True Range (ATR) 0.28 0.36
MACD -0.05 -0.05
Stochastic Oscillator 9.59 52.85

Price Performance

Historical Comparison
PTLO
EOLS

About PTLO Portillo's Inc.

Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. The company owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, sides and soup, and others.

About EOLS Evolus Inc.

Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.

Share on Social Networks: